Literature DB >> 27553792

Impact of prior interventions on outcomes during per oral endoscopic myotomy.

Brian E Louie1, Andreas M Schneider2, Drew B Schembre3, Ralph W Aye2.   

Abstract

BACKGROUND: Per oral endoscopic myotomy (POEM) is performed by accessing the submucosal space of the esophagus. This space may be impacted by prior interventions such as submucosal injections, dilations or previous myotomies. These interventions could make POEM more difficult and may deter surgeons during their initial experience. We sought to determine the impact of prior interventions on our early experience.
METHODS: Prospective, single-center study of consecutive patients undergoing POEM. Patients were grouped according to their anticipated complexity: Group A: no prior interventions (N = 19); Group B: prior interventions such as submucosal injections and/or dilations (N = 11) and  Group C: sigmoidal esophagus, prior esophageal surgery, balloon dilation >30 mm (N = 8). We compared operative times, inadvertent mucosotomy rates, complications and short-term outcomes between groups.
RESULTS: A total of 38 patients underwent POEM for achalasia subtypes: I (N = 9), II (N = 19) and III (N = 7). Three had other dysmotility disorders. Patients between the groups were similar. Operative times were similar between Group A and Group B but significantly longer for Group C (133 vs. 132 vs. 210 min, p = 0.001). Mucosotomy rates were highest in Group A (6/19) with 1 each in Group B/C (p = 0.46). One patient in Group A required an esophageal stent. Eckardt scores improved in all groups (6-1; 8-2; 6-0.5, p = 0.73), and postoperative GERD-HRQL scores were similar. One patient underwent laparoscopic myotomy for persistent symptoms with no improvement, and one patient underwent esophagectomy for a sigmoid esophagus and persistent symptoms despite adequate myotomy.
CONCLUSION: A prior intervention does not seem to impact short-term clinical outcomes with POEM. Patients who had submucosal injections or small caliber dilations are similar to patients with no prior inventions; however, patients with a sigmoid-shaped esophagus and/or a prior myotomy require nearly double the operative time. Endoscopists undertaking POEM should consider these during their learning curve.

Entities:  

Keywords:  Achalasia; Balloon dilation; Botulinum toxin; Myotomy; Outcomes; Per oral endoscopic myotomy (POEM)

Mesh:

Year:  2016        PMID: 27553792     DOI: 10.1007/s00464-016-5182-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  A new dysphagia score with objective validation.

Authors:  M Dakkak; J R Bennett
Journal:  J Clin Gastroenterol       Date:  1992-03       Impact factor: 3.062

2.  Minimally invasive surgery for achalasia: an 8-year experience with 168 patients.

Authors:  M G Patti; C A Pellegrini; S Horgan; M Arcerito; P Omelanczuk; A Tamburini; U Diener; T R Eubanks; L W Way
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

3.  A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders.

Authors:  Lee L Swanström; Erwin Rieder; Christy M Dunst
Journal:  J Am Coll Surg       Date:  2011-10-13       Impact factor: 6.113

4.  Per-Oral Endoscopic Myotomy: A Series of 500 Patients.

Authors:  Haruhiro Inoue; Hiroki Sato; Haruo Ikeda; Manabu Onimaru; Chiaki Sato; Hitomi Minami; Hiroshi Yokomichi; Yasutoshi Kobayashi; Kevin L Grimes; Shin-ei Kudo
Journal:  J Am Coll Surg       Date:  2015-04-11       Impact factor: 6.113

5.  Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD).

Authors:  I K Wiklund; O Junghard; E Grace; N J Talley; M Kamm; S Veldhuyzen van Zanten; P Paré; N Chiba; D S Leddin; M A Bigard; R Colin; P Schoenfeld
Journal:  Eur J Surg Suppl       Date:  1998

6.  Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome.

Authors:  Steven Rakita; Mark Bloomston; Desiree Villadolid; Donald Thometz; Emmanuel Zervos; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

7.  Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy.

Authors:  Sean B Orenstein; Siavash Raigani; Yuhsin V Wu; Eric M Pauli; Melissa S Phillips; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2014-09-24       Impact factor: 4.584

8.  Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment.

Authors:  Giuseppe Portale; Mario Costantini; Christian Rizzetto; Emanuela Guirroli; Martina Ceolin; Renato Salvador; Ermanno Ancona; Giovanni Zaninotto
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

9.  Difficult myotomy is not determined by preoperative therapy and does not impact outcome.

Authors:  Sarah M Cowgill; Desiree V Villadolid; Sam Al-Saadi; Alexander S Rosemurgy
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

10.  Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease.

Authors:  V Velanovich
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  9 in total

1.  Recent Advances in Third-Space Endoscopy.

Authors:  Zaheer Nabi; D Nageshwar Reddy; Mohan Ramchandani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-04

2.  Use of a report card to evaluate outcomes of achalasia surgery: beyond the Eckardt score.

Authors:  Ealaf Shemmeri; Ralph W Aye; Alexander S Farivar; Adam J Bograd; Brian E Louie
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

Review 3.  The current state of per oral endoscopic myotomy for achalasia.

Authors:  Shane P Smith; Brian E Louie
Journal:  J Vis Surg       Date:  2017-09-14

4.  Use of the functional luminal imaging probe in pediatrics: A comparison study of patients with achalasia before and after endoscopic dilation and non-achalasia controls.

Authors:  Alain J Benitez; Stephen Budhu; Cassandra Burger; Rossella Turco; Lance Ballester; Amit Shah; Kristle Lynch; Kristin Fiorino; Calies Menard-Katcher; Amanda B Muir; Petar Mamula
Journal:  Neurogastroenterol Motil       Date:  2021-04-19       Impact factor: 3.598

Review 5.  An Updated Meta-analysis: Similar Clinical Efficacy of Anterior and Posterior Approaches in Peroral Endoscopic Myotomy (POEM) for Achalasia.

Authors:  Weina Jing; Xinyue Luo; Jinlin Yang; Junchao Wu; Yuxiang Chen; Kai Deng
Journal:  Gastroenterol Res Pract       Date:  2022-04-11       Impact factor: 1.919

6.  Peroral endoscopic myotomy (POEM) vs pneumatic dilation (PD) in treatment of achalasia: A meta-analysis of studies with ≥ 12-month follow-up.

Authors:  Andrew Ofosu; Babu P Mohan; Yervant Ichkhanian; Maen Masadeh; John Febin; Mohamed Barakat; Daryl Ramai; Saurabh Chandan; Gulara Haiyeva; Shahab R Khan; Mohamad Aghaie Meybodi; Antonio Facciorusso; Alessandro Repici; Sachin Wani; Nirav Thosani; Mouen A Khashab
Journal:  Endosc Int Open       Date:  2021-06-21

7.  New endoscopic classification of esophageal mucosa in achalasia: A predictor for submucosal fibrosis.

Authors:  Xiuxue Feng; Enqiang Linghu; Ningli Chai; Hui Ding
Journal:  Saudi J Gastroenterol       Date:  2018 Mar-Apr       Impact factor: 2.485

8.  Gas Leak and Mucosal Injury During Endoscopic Esophageal Myotomy After Previous Myotomy: A Single-Center Experience.

Authors:  Salih Samo; Falak Hamo; Anand S Jain; Rushikesh H Shah; Vaishali Patel; Lucie F Calderon; Mengdan Xie; Parit Mekaroonkamol; Steven A Keilin; Qiang Cai
Journal:  Clin Exp Gastroenterol       Date:  2021-05-20

9.  Revisional Therapy for Recurrent Symptoms After Heller Myotomy for Achalasia.

Authors:  Pamela Milito; Stefano Siboni; Andrea Lovece; Erika Andreatta; Emanuele Asti; Luigi Bonavina
Journal:  J Gastrointest Surg       Date:  2021-08-02       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.